NasdaqGS - Delayed Quote USD
Boundless Bio, Inc. (BOLD)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 4:02 PM EDT
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
129,894.0000
76,829.0000
113,719.0000
Total Liabilities Net Minority Interest
256,976.0000
158,525.0000
151,908.0000
Total Equity Gross Minority Interest
-127,082.0000
-81,696.0000
-38,189.0000
Total Capitalization
-127,082.0000
-81,696.0000
-38,189.0000
Common Stock Equity
-127,082.0000
-81,696.0000
-38,189.0000
Capital Lease Obligations
2,195.0000
5,183.0000
377.0000
Net Tangible Assets
-127,082.0000
-81,696.0000
-38,189.0000
Working Capital
114,845.0000
60,309.0000
70,703.0000
Invested Capital
-127,082.0000
-81,696.0000
-38,189.0000
Tangible Book Value
-127,082.0000
-81,696.0000
-38,189.0000
Total Debt
2,195.0000
5,183.0000
377.0000
Share Issued
22,239.3330
22,239.3330
22,239.3330
Ordinary Shares Number
22,239.3330
22,239.3330
22,239.3330
12/31/2021 - 3/28/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTV Artiva Biotherapeutics, Inc.
12.17
-4.77%
ANRO Alto Neuroscience, Inc.
14.43
+1.12%
PROK ProKidney Corp.
1.9700
-0.51%
MGX Metagenomi, Inc.
1.9600
-1.51%
CNTX Context Therapeutics Inc.
2.0400
+1.49%
CTNM Contineum Therapeutics, Inc.
16.38
-0.61%
AVTE Aerovate Therapeutics, Inc.
2.3700
+2.16%
TRML Tourmaline Bio, Inc.
28.26
-2.99%
ERAS Erasca, Inc.
2.9100
+3.93%
BCAX Bicara Therapeutics Inc.
21.96
+7.44%